Marinus Pharmaceuticals reported $19.54M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
ALKERMES ALKS:US $ 462.36M 8.93M
Amgen AMGN:US $ 12886M 702M
Aptinyx Inc APTX:US $ 4.74M 949K
Biogen BIIB:US $ 3946.6M 351.6M
Eisai 4523:JP Y 313333M 8340M
Enanta Pharmaceuticals ENTA:US $ 30.74M 7.15M
Esperion Therapeutics ESPR:US $ 79.08M 5.73M
Gilead Sciences GILD:US $ 8558M 3052M
Intercept Pharmaceuticals ICPT:US $ 151.04M 15.78M
Intra Cellular Therapies ITCI:US $ 59.07M 5.72M
Marinus Pharmaceuticals MRNS:US $ 19.54M 21.03M
Minerva Neurosciences NERV:US $ 3.25M 0.43M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Ptc Therapeutics PTCT:US $ 476.78M 32.57M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Sarepta Therapeutics SRPT:US $ 454.96M 2.23M
Supernus Pharmaceuticals SUPN:US $ 284.56M 30.82M
Vertex Pharmaceuticals VRTX:US $ 2180.2M 38.2M
YTE INCY:US $ 886.16M 31.86M